Integrated serum pharmacochemistry, 16S rDNA sequencing, and metabolomics to reveal the material basis and mechanism of Shouhui Tongbian capsule against diphenoxylate-induced slow transit constipation in rats

Bibliographic Details
Title: Integrated serum pharmacochemistry, 16S rDNA sequencing, and metabolomics to reveal the material basis and mechanism of Shouhui Tongbian capsule against diphenoxylate-induced slow transit constipation in rats
Authors: Jiaying Yang, He Xiao, Jingchun Yao, Pin Zhang, Bojiao Yi, Zhengyu Fang, Na Guo, Yongxia Guan, Guimin Zhang
Source: Chinese Medicine, Vol 19, Iss 1, Pp 1-18 (2024)
Publisher Information: BMC, 2024.
Publication Year: 2024
Collection: LCC:Other systems of medicine
Subject Terms: Slow transit constipation, Chinese medicine, Lipidomics, Intestinal microflora, Short-chain fatty acid, Other systems of medicine, RZ201-999
More Details: Abstract Background Slow transit constipation (STC) is highly prevalent and has rising incidence. Shouhui Tongbian capsule (SHTB) is a traditional Chinese Medicine formula with extensive and highly efficacious usage in STC treatment, however, its mechanism of action, especially the regulation of microbiome and lipid metabolites, remains unclear. Methods After quality control of SHTB using LC‒MS to obtain its material basis, we tried to elucidate the cohesive modulatory network of SHTB against STC using hyphenated methods from microbiomics, lipidomics, mass spectrometry imaging (MSI) and molecular methods. Results SHTB could repair intestinal barrier damage, reduce systemic inflammation and increase intestinal motility in a diphenoxylate-induced STC rat model. Based on 16S rDNA sequencing results, SHTB rehabilitated the abnormal changes in Alloprevotella, Coprococcus, Marvinbryantia, etc., which were associated with STC symptoms. Meanwhile, microbial functional prediction showed that lipid metabolism was improved with SHTB administration. The differential lipids, including fatty acids, lysophosphatidylcholine, phosphatidylcholine, sphingomyelin triglyceride and ceramide, that are closely related to STC disease and SHTB efficacy. Furthermore, SHTB significantly reversed the abnormal expression of these key target enzymes in colon samples, including CTP-phosphocholine cytidylyltransferase, CTP-phosphoethanolamine cytidylyltransferase, phosphatidic acid phosphatase, acid sphingomyelinase etc. Conclusions Combined analysis demonstrated that SHTB reducing lipid accumulation and recovery of intestinal microbial homeostasis was the critical mechanism by which SHTB treats STC.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1749-8546
Relation: https://doaj.org/toc/1749-8546
DOI: 10.1186/s13020-024-01015-8
Access URL: https://doaj.org/article/e5b5a6866a5049f183d75e4035dad261
Accession Number: edsdoj.5b5a6866a5049f183d75e4035dad261
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:17498546
DOI:10.1186/s13020-024-01015-8
Published in:Chinese Medicine
Language:English